Urethral Resistive Index (URI) as a non-invasive test for urethral blockage
Official title: Urethral Resistive Index (URI): A New Uroflowmetric Parameter in the Non-Invasive Diagnosis of Urethral Obstruction
Run by Ankara City Hospital Bilkent · NCT07403786 · Data updated 2026-11-12
This project tests a new, painless urine-flow measure called the Urethral Resistive Index (URI) to see if it can detect urethral strictures in men.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | Men only |
| Enrollment | 60 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara, Universiteler) |
| Status | Recruiting |
| Started | February 10, 2026 |
| Main results expected | February 10, 2027 |
| Study ends | March 10, 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07403786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Men aged 18–80 with suspected urethral stricture scheduled for confirmatory surgery or healthy male volunteers without lower urinary tract symptoms are ideal candidates.
✕Probably not a fit
Patients with voided volumes under 150 mL, obstruction from other causes (e.g., BPH), neurogenic bladder, or severe comorbidities are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, cross-sectional observational diagnostic accuracy project enrolling 60 men (30 with suspected urethral stricture and 30 healthy controls). Each participant performs two non-invasive uroflowmetry tests: a standard natural voiding and a forced void using the Valsalva maneuver, and the URI is calculated as Qmax_forced divided by Qmax_normal. The stricture group includes men scheduled for urethral surgery with intraoperative confirmation, while controls are age-matched healthy volunteers without lower urinary tract symptoms. Diagnostic performance will be analyzed using ROC curves to determine AUC and an optimal cutoff value for URI at Ankara Bilkent City Hospital.
Why it matters
Potential benefit: If successful, the URI could offer a quick, painless screening test that reduces the need for invasive procedures to confirm urethral strictures.
How similar studies have gone: The use of forced uroflowmetry concepts has precedent, but the URI parameter itself is novel and largely untested in clinical populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male participants aged between 18 and 80 years. * For the Stricture Group: Patients scheduled for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the diagnosis is confirmed intraoperatively. * For the Control Group: Healthy male volunteers without any lower urinary tract symptoms. * Voluntary signing of the Informed Consent Form. Exclusion Criteria: * Voiding volume less than 150 mL. * Causes of obstruction other than stricture, such as Benign Prostatic Hyperplasia (BPH). * Diagnosis of neurogenic bladder dysfunction or a history of neurological disease affecting bladder function. * Presence of severe comorbidities.
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Universiteler, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Yusuf Gökkurt
- Email: yusufgokkurt@gmail.com
- Phone: +90-506-791-0557
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intraoperative Lidocaine or Dexmedetomidine to Help Postoperative Pain After Urethral Reconstruction
This study tests whether giving lidocaine or dexmedetomidine during urethral reconstruction can reduce pain after surgery and lower the chance of long-lasting pain.
-
Comparing cheek (buccal) tissue versus penile skin grafts for repairing long anterior urethral strictures
This will test whether cheek (buccal) tissue or penile skin works better to repair long anterior urethral strictures in men who need urethroplasty.
-
Paclitaxel-coated versus standard dilatation balloon for recurrent urethral stricture
This trial tests if a paclitaxel-coated dilatation balloon (Optilume) reduces the chance of urethral stricture coming back compared with a non-coated balloon in adults who have had previous dilations or DVIU.
-
Database for patients with urethral stricture undergoing surgery
This study is trying to gather information from patients with urethral stricture who are having surgery to see how well different surgical methods work and how they affect quality of life.
-
Study on urethroplasty for urethral stricture disease
This study is testing how well urethroplasty works for treating urethral stricture disease in different groups of people, including men, women, transgender individuals, and children.
-
Using engineered urethral constructs to treat urethral strictures in men
This study is testing a new way to treat urethral strictures in men by using specially grown tissue from their own bladder to see if it helps them feel better over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.